JPWO2020261231A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020261231A5
JPWO2020261231A5 JP2021576820A JP2021576820A JPWO2020261231A5 JP WO2020261231 A5 JPWO2020261231 A5 JP WO2020261231A5 JP 2021576820 A JP2021576820 A JP 2021576820A JP 2021576820 A JP2021576820 A JP 2021576820A JP WO2020261231 A5 JPWO2020261231 A5 JP WO2020261231A5
Authority
JP
Japan
Prior art keywords
cancer
immune cell
cell
receptor
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021576820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538425A (ja
JP7829911B2 (ja
JP2022538425A5 (https=
Publication date
Priority claimed from PCT/KR2019/010244 external-priority patent/WO2020032784A1/ko
Application filed filed Critical
Priority claimed from PCT/IB2020/056097 external-priority patent/WO2020261231A1/en
Publication of JP2022538425A publication Critical patent/JP2022538425A/ja
Publication of JP2022538425A5 publication Critical patent/JP2022538425A5/ja
Publication of JPWO2020261231A5 publication Critical patent/JPWO2020261231A5/ja
Priority to JP2025076601A priority Critical patent/JP2025118764A/ja
Application granted granted Critical
Publication of JP7829911B2 publication Critical patent/JP7829911B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021576820A 2019-06-27 2020-06-26 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 Active JP7829911B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076601A JP2025118764A (ja) 2019-06-27 2025-05-02 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201962867503P 2019-06-27 2019-06-27
US62/867,503 2019-06-27
KRPCT/KR2019/010244 2019-08-12
PCT/KR2019/010244 WO2020032784A1 (ko) 2018-08-10 2019-08-12 Hla-dr에 결합하는 키메라 항원 수용체 및 car-t 세포
US16/715,462 2019-12-16
US16/715,462 US11013765B2 (en) 2018-08-10 2019-12-16 Chimeric antigen receptor that binds HLA-DR and CAR-T cell
US202062991493P 2020-03-18 2020-03-18
US62/991,493 2020-03-18
US202063004827P 2020-04-03 2020-04-03
US63/004,827 2020-04-03
US202063043237P 2020-06-24 2020-06-24
US63/043,237 2020-06-24
PCT/IB2020/056097 WO2020261231A1 (en) 2019-06-27 2020-06-26 Chimeric antigen receptor with 4-1bb costimulatory domain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076601A Division JP2025118764A (ja) 2019-06-27 2025-05-02 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体

Publications (4)

Publication Number Publication Date
JP2022538425A JP2022538425A (ja) 2022-09-02
JP2022538425A5 JP2022538425A5 (https=) 2023-06-15
JPWO2020261231A5 true JPWO2020261231A5 (https=) 2023-06-15
JP7829911B2 JP7829911B2 (ja) 2026-03-16

Family

ID=74061779

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021576820A Active JP7829911B2 (ja) 2019-06-27 2020-06-26 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体
JP2025076601A Withdrawn JP2025118764A (ja) 2019-06-27 2025-05-02 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076601A Withdrawn JP2025118764A (ja) 2019-06-27 2025-05-02 ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体

Country Status (8)

Country Link
EP (1) EP3990626A4 (https=)
JP (2) JP7829911B2 (https=)
CN (2) CN114080452B (https=)
AU (1) AU2020307673A1 (https=)
BR (1) BR112021026406A2 (https=)
CA (1) CA3144875A1 (https=)
MX (1) MX2021015967A (https=)
WO (1) WO2020261231A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3835320A4 (en) * 2018-08-10 2022-06-01 Eutilex Co., Ltd. Chimeric antigen receptor binding to hla-dr, and car-t cell
EP3962527A4 (en) 2019-04-30 2023-11-01 Senti Biosciences, Inc. CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
KR102671410B1 (ko) * 2021-03-03 2024-06-04 진화섭 RANK 리간드(RANK ligand)에 특이적으로 결합하는 키메릭 항원 수용체 및 이의 용도
JP2025509769A (ja) * 2022-03-15 2025-04-11 ニューヨーク・ゲノム・センター，インコーポレーテッド 改善した免疫療法のための融合タンパク質を含む方法及び組成物
WO2025103439A1 (zh) * 2023-11-16 2025-05-22 广州瑞风生物科技有限公司 一种嵌合抗原受体及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113564A1 (en) * 2003-11-05 2005-05-26 St. Jude Children's Research Hospital Chimeric receptors with 4-1BB stimulatory signaling domain
JP4331227B2 (ja) * 2004-07-09 2009-09-16 中外製薬株式会社 抗グリピカン３抗体
AU2013204922B2 (en) * 2012-12-20 2015-05-14 Celgene Corporation Chimeric antigen receptors
WO2014160627A1 (en) * 2013-03-25 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-cd276 polypeptides, proteins, and chimeric antigen receptors
WO2015069922A2 (en) * 2013-11-06 2015-05-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Alk antibodies, conjugates, and chimeric antigen receptors, and their use
KR101605421B1 (ko) * 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
MX383150B (es) * 2014-06-02 2025-03-13 Us Health Receptores quiméricos de antígeno que tienen como diana a cd-19.
US10195272B2 (en) * 2015-03-02 2019-02-05 The Nemours Foundation Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases
JP7010473B2 (ja) * 2015-06-04 2022-02-10 ユニバーシティ オブ サザン カリフォルニア Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法
CN114181960B (zh) * 2015-10-09 2024-08-23 美天施生物科技有限公司 嵌合抗原受体和使用方法
CN105906720A (zh) * 2016-05-16 2016-08-31 武汉汉密顿生物科技股份有限公司 靶向性嵌合抗原受体修饰的免疫细胞及其制备方法和应用
CN106279438B (zh) * 2016-08-24 2019-10-22 北京领柯生物科技有限公司 新型嵌合抗原受体及其用途
CN108165568B (zh) * 2016-12-07 2020-12-08 上海恒润达生生物科技有限公司 一种培养CD19CAR-iNKT细胞方法及用途
WO2018106993A1 (en) * 2016-12-09 2018-06-14 H. Lee Moffitt Cancer Center And Research Institute Inc. Tlr9-binding chimeric antigen receptors
WO2018132513A1 (en) * 2017-01-10 2018-07-19 The General Hospital Corporation T cells experessing a chimeric antigen receptor
JP2020508080A (ja) * 2017-02-21 2020-03-19 ユーティレックス カンパニー リミテッド Ｈｌａ−ｄｒ ｃａｒ−ｔ組成物ならびにその作製方法および使用方法
WO2018156711A1 (en) * 2017-02-22 2018-08-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Il13ra2-binding chimeric antigen receptors
CN108728459B (zh) * 2017-04-24 2023-08-04 上海恒润达生生物科技股份有限公司 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途
WO2018236909A1 (en) * 2017-06-20 2018-12-27 La Jolla Institute For Allergy And Immunology Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis
US10442867B2 (en) * 2017-07-31 2019-10-15 Lentigen Technology, Inc. Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
CN108715859B (zh) * 2018-05-31 2021-08-03 中国医学科学院血液病医院(中国医学科学院血液学研究所) 靶向cd22的嵌合抗原受体及其应用
JPWO2020017479A1 (ja) * 2018-07-17 2021-08-02 ノイルイミューン・バイオテック株式会社 抗ｇｐｃ３一本鎖抗体を含むｃａｒ

Similar Documents

Publication Publication Date Title
JP2021520788A5 (https=)
JP2021000103A5 (https=)
KR102879284B1 (ko) 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
US11564945B2 (en) Chimeric antigen receptor and use thereof
JP2019516352A5 (https=)
HRP20221348T1 (hr) Kimerni receptori i postupci njihove uporabe
JPWO2020180591A5 (https=)
JP2020513839A5 (https=)
JP2020506700A5 (https=)
JP2017522879A5 (https=)
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JP2021530233A5 (https=)
JP2017524367A5 (https=)
JPWO2019200007A5 (https=)
JP2018527014A5 (https=)
JP7723420B2 (ja) Ｂ細胞標的化並列ＣＡＲ（ｐＣＡＲ）治療的薬剤
RU2019128921A (ru) Антитело к il-13ra2 и его применение
JPWO2021173985A5 (https=)
WO2024037477A1 (zh) 双特异性嵌合抗原受体和免疫细胞、制备方法、应用及肿瘤治疗药品
JPWO2020261231A5 (https=)
WO2025148750A1 (zh) 膜表达il-10及其用途
JPWO2020018695A5 (https=)
JPWO2021186397A5 (https=)
RU2022101671A (ru) Химерный антигенный рецептор с костимулирующим доменом 4-1bb
JPWO2023068382A5 (https=)